JCVI advises inviting people on Learning Disability Register for vaccine

The advice of the Joint Committee on Vaccination and Immunisation (JCVI) remains that adults with severe and profound learning disabilities, and those with learning disabilities in long-stay nursing and residential care settings, should be offered the vaccine in priority group 6 (people with Down’s syndrome are included in group 4). Adults with less severe learning disabilities are not currently prioritised. However, GP systems may not always capture the severity of someone’s disability, meaning some adults who are more severely affected by learning disabilities may not be invited for vaccination alongside people with other long-term health conditions. JCVI asked the OpenSAFELY team to perform an updated analysis in those…

Comments Off on JCVI advises inviting people on Learning Disability Register for vaccine

Page not found – GOV.UK

We use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content from their services. Source link

Comments Off on Page not found – GOV.UK

Vaping better than nicotine replacement therapy for stopping smoking, evidence suggests

Public Health England’s (PHE) seventh independent report on vaping in England, carried out by researchers at King’s College London, found that: nicotine vaping products were the most popular aid (27.2%) used by smokers trying to quit in England in 2020 it is estimated that in 2017, more than 50,000 smokers stopped smoking with the aid of a vaping product who would otherwise have carried on smoking 38% of smokers in 2020 believed that vaping is as harmful as smoking – 15% believed that vaping is more harmful using a vaping product as part of a quit attempt in local stop smoking services had some of the highest quit…

Comments Off on Vaping better than nicotine replacement therapy for stopping smoking, evidence suggests

Vaping in England: evidence update February 2021

Vaping in England: an evidence update including vaping for smoking cessation Ref: PHE publications gateway number: GW-1946 PDF, 2.38MB, 247 pages This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use. Source link

Comments Off on Vaping in England: evidence update February 2021

Physical activity: understanding and addressing inequalities

Understanding and addressing inequalities in physical activity Ref: PHE publications gateway number: GW-1897 PDF, 1.73MB, 211 pages This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use. Source link

Comments Off on Physical activity: understanding and addressing inequalities

First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose

Data analysed by Public Health England (PHE) shows the Pfizer-BioNTech vaccine provides high levels of protection against infection and symptomatic disease from the first dose. Early data from PHE’s SIREN study shows a promising impact on infection in healthcare workers aged under 65. Healthcare workers in the study are tested for coronavirus (COVID-19) every 2 weeks – whether or not they have symptoms. Data shows one dose reduces the risk of catching infection by more than 70%, rising to 85% after the second dose. This suggests the vaccine may also help to interrupt virus transmission, as you cannot spread the virus if you do not have infection. PHE’s…

Comments Off on First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose

PHE monitoring of the effectiveness of COVID-19 vaccination

PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England Ref: PHE publications gateway number: GW-1970 PDF, 969KB, 15 pages This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use. Source link

Comments Off on PHE monitoring of the effectiveness of COVID-19 vaccination